MedTrace Logo

Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers

NCT07294521 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-03-11

No results posted yet for this study

Summary

Platelet rich Fibrin (PRF) gel is an emerging as a novel treatment option for chronic leg ulcers and has the potential to become the 1st line option in these conditions. The objective of our study will be to assess the efficacy of PRF gel dressing in patients with non-infective chronic leg ulcers.

Conditions

  • Chronic Leg Ulcer

Interventions

BIOLOGICAL

Platelet rich Fibrin (PRF)

PRF is derived solely from the patient's own blood and does not contain any non-autologous additives, such as anticoagulants or bovine thrombin, as first-generation platelet concentrates (like some forms of PRP)

Sponsors & Collaborators

  • Pak Emirates Military Hospital

    lead OTHER

Principal Investigators

  • Prof. Moizza Tahir, MBBS, FCPS, FRCP · Pak Emirates Military Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-16
Primary Completion
2026-04-12
Completion
2026-05-12

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07294521 on ClinicalTrials.gov